Few high-quality controlled studies have examined NBAC pharmacotherapies for AWS and AUD to date. Many of the reviewed studies are underpowered or open-label pilot studies, making interpretations of the potential …
Few high-quality controlled studies have examined NBAC pharmacotherapies for AWS and AUD to date. Many of the reviewed studies are underpowered or open-label pilot studies, making interpretations of the potential …